← FDA Drug Approvals (Drugs@FDA)

GADOTERATE MEGLUMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VIWIT PHARM · Approved 2026-08-10

Drug application

FDA Application #

ANDA219286

Application type

Abbreviated New Drug Application (Generic)

Brand name

GADOTERATE MEGLUMINE

Generic name

Gadoterate Meglumine

Active ingredients

GADOTERATE MEGLUMINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

VIWIT PHARM

First approval

2026-08-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown